NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae

Xinjie Liu1, Vinita S Chauhan, Amy B Young

  • 1Department of Pediatrics, Qilu Hospital, Shandong University, Jinan, Shandong, People's Republic of China.

Glia
|January 22, 2010
PubMed

Insights

Resident brain cells, microglia and astrocytes, use nucleotide-binding oligomerization domain-2 (NOD2) to detect bacteria. NOD2 is crucial for initiating inflammation in response to Streptococcus pneumoniae, a cause of meningitis.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Resident central nervous system (CNS) cells, including microglia and astrocytes, play a key role in neuroinflammation.
  • The mechanisms by which glial cells detect microbial threats are increasingly understood.
  • Nucleotide-binding oligomerization domain-2 (NOD2), an intracellular receptor, recognizes bacterial peptidoglycans.

Purpose of the Study:

  • To investigate the role of NOD2 in glial cell responses to Streptococcus pneumoniae, a Gram-positive pathogen.
  • To determine if NOD2 is essential for CNS inflammation induced by S. pneumoniae.

Main Methods:

  • Primary murine microglia and astrocytes were stimulated with intact S. pneumoniae.
  • Activation of NF-kB and cytokine production were measured.
  • In vivo studies assessed inflammatory mediator levels, astrogliosis, and demyelination following S. pneumoniae administration.

Main Results:

  • Intact S. pneumoniae activated NF-kB and cytokine production in microglia and astrocytes.
  • NOD2 was essential for maximal glial responses to intact S. pneumoniae, but not cellular lysates.
  • NOD2 deficiency protected against elevated inflammatory mediators, astrogliosis, and demyelination in vivo.

Conclusions:

  • NOD2 is a critical cytosolic pattern recognition receptor for detecting Gram-positive bacterial meningitis pathogens.
  • NOD2 signaling is essential for the neuroinflammatory response to Streptococcus pneumoniae.
  • Targeting NOD2 may offer a therapeutic strategy for streptococcal meningitis.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...